<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Topical corticosteroids as adjunctive therapy for bacterial keratitis - Herretes, S - 2014 | Cochrane Library</title> <meta content="Topical corticosteroids as adjunctive therapy for bacterial keratitis - Herretes, S - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005430.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Topical corticosteroids as adjunctive therapy for bacterial keratitis - Herretes, S - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005430.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005430.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Topical corticosteroids as adjunctive therapy for bacterial keratitis" name="citation_title"/> <meta content="Samantha Herretes" name="citation_author"/> <meta content="University of Miami School of Medicine" name="citation_author_institution"/> <meta content="sherretes@gmail.com" name="citation_author_email"/> <meta content="Xue Wang" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health" name="citation_author_institution"/> <meta content="Johann MG Reyes" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD005430.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/10/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005430.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005430.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005430.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenal Cortex Hormones [*therapeutic use]; Chemotherapy, Adjuvant [methods]; Eye Infections, Bacterial [*drug therapy]; Keratitis [*drug therapy, microbiology]; Randomized Controlled Trials as Topic; Visual Acuity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005430.pub3&amp;doi=10.1002/14651858.CD005430.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="9nGOjNGw";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005430\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005430\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005430.pub3",title:"Topical corticosteroids as adjunctive therapy for bacterial keratitis",firstPublishedDate:"Oct 16, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9nGOjNGw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005430.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005430.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005430.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005430.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005430.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005430.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005430.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005430.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005430.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005430.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4162 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005430.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-sec-0030"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-sec-0031"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-sec-0082"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/appendices#CD005430-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/table_n/CD005430StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/table_n/CD005430StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Topical corticosteroids as adjunctive therapy for bacterial keratitis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information#CD005430-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Samantha Herretes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information#CD005430-cr-0003">Xue Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information#CD005430-cr-0004">Johann MG Reyes</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information/en#CD005430-sec-0104">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 October 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005430.pub3">https://doi.org/10.1002/14651858.CD005430.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005430-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005430-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005430-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005430-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005430-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005430-abs-0001" lang="en"> <section id="CD005430-sec-0001"> <h3 class="title" id="CD005430-sec-0001">Background</h3> <p>Bacterial keratitis is a serious ocular infectious disease that can lead to severe visual disability. Risk factors for bacterial corneal infection include contact lens wear, ocular surface disease, corneal trauma, and previous ocular or eyelid surgery. Topical antibiotics constitute the mainstay of treatment in cases of bacterial keratitis, whereas the use of topical corticosteroids as an adjunctive therapy to antibiotics remains controversial. Topical corticosteroids are usually used to control inflammation using the smallest amount of the drug. Their use requires optimal timing, concomitant antibiotics, and careful follow‐up. </p> </section> <section id="CD005430-sec-0002"> <h3 class="title" id="CD005430-sec-0002">Objectives</h3> <p>The objective of the review was to assess the effectiveness and safety of corticosteroids as adjunctive therapy for bacterial keratitis. Secondary objectives included evaluation of health economic outcomes and quality of life outcomes. </p> </section> <section id="CD005430-sec-0003"> <h3 class="title" id="CD005430-sec-0003">Search methods</h3> <p>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2014, Issue 6), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to July 2014), EMBASE (January 1980 to July 2014), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to July 2014), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 14 July 2014. We also searched the Science Citation Index to identify additional studies that had cited the only trial included in the original version of this review, reference lists of included trials, earlier reviews, and the American Academy of Ophthalmology guidelines. We also contacted experts to identify any unpublished and ongoing randomized trials. </p> </section> <section id="CD005430-sec-0004"> <h3 class="title" id="CD005430-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) that had evaluated adjunctive therapy with topical corticosteroids in people with bacterial keratitis who were being treated with antibiotics. </p> </section> <section id="CD005430-sec-0005"> <h3 class="title" id="CD005430-sec-0005">Data collection and analysis</h3> <p>We used the standard methodological procedures expected by The Cochrane Collaboration.</p> </section> <section id="CD005430-sec-0006"> <h3 class="title" id="CD005430-sec-0006">Main results</h3> <p>We found four RCTs that met the inclusion criteria of this review. The total number of included participants was 611 (612 eyes), ranging from 30 to 500 participants per trial. One trial was included in the previous version of the review, and we identified three additional trials through the updated searches in July 2014. One of the three smaller trials was a pilot study of the largest study: the Steroids for Corneal Ulcers Trial (SCUT). All trials compared the treatment of bacterial keratitis with topical corticosteroid and without topical corticosteroid and had follow‐up periods ranging from two months to one year. These trials were conducted in the USA, Canada, India, and South Africa. </p> <p>All trials reported data on visual acuity ranging from three weeks to one year, and none of them found any important difference between the corticosteroid group and the control group. The pilot study of the SCUT reported that time to re‐epithelialization in the steroid group was 53% slower than the placebo group after adjusting for baseline epithelial defect size (hazard ratio (HR) 0.47; 95% confidence interval (CI) 0.23 to 0.94). However, the SCUT did not find any important difference in time to re‐epithelialization (HR 0.92; 95% CI 0.76 to 1.11). For adverse events, none of the three small trials found any important difference between the two treatment groups. The investigators of the largest trial reported that more patients in the control group developed intraocular pressure (IOP) elevation (risk ratio (RR) 0.20; 95% CI 0.04 to 0.90). One trial reported quality of life and concluded that there was no difference between the two groups (data not available). We did not find any reports regarding economic outcomes. </p> <p>Although the four trials were generally of good methodological design, all trials had considerable losses to follow‐up (10% or more) in the final analyses. Further, three of the four trials were underpowered to detect treatment effect differences between groups and inconsistency in outcome measurements precluded meta‐analyses for most outcomes relevant to this review. </p> </section> <section id="CD005430-sec-0007"> <h3 class="title" id="CD005430-sec-0007">Authors' conclusions</h3> <p>There is inadequate evidence as to the effectiveness and safety of adjunctive topical corticosteroids compared with no topical corticosteroids in improving visual acuity, infiltrate/scar size, or adverse events among participants with bacterial keratitis. Current evidence does not support a strong effect of corticosteroid, but may be due to insufficient power to detect a treatment effect. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005430-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005430-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005430-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005430-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005430-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005430-abs-0004">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005430-abs-0003" lang="en"> <h3>Corticosteroid eye drops used in addition to standard antibiotic therapy in the treatment of bacterial keratitis </h3> <p><b>Review question</b> </p> <p>We reviewed the available information regarding the added effect of corticosteroid eye drops in people with bacterial keratitis (corneal ulcers) who were also being treated with antibiotics. </p> <p><b>Background</b> </p> <p>Bacterial keratitis, or corneal inflammation due to bacterial infection, is a sight‐threatening condition. Contact lens wear, ocular surface disease, corneal trauma, and previous ocular or eyelid surgery have been linked to bacterial keratitis. Antibiotic eye drops are the standard treatment for eyes with bacterial keratitis. Corticosteroid eye drops also may be used to control the inflammation from infection. Eye doctors disagree about whether corticosteroid eye drops should be used with antibiotics to treat this condition due to potential side effects of using steroids in the eye. </p> <p><b>Study characteristics</b> </p> <p>We found four studies in which antibiotics alone had been compared with antibiotics plus corticosteroids for the treatment of bacterial keratitis. These studies were conducted in the USA, Canada, India, and South Africa, and included a total of 612 eyes of 611 participants. The largest study included 500 participants followed for one year. The three smaller studies followed participants for two to three months. The evidence is current to July 2014. </p> <p><b>Key results</b> </p> <p>None of the four studies reported an important difference between topical corticosteroid therapy and placebo or control treatment for reduction in ulcer size, change in visual acuity, adverse events, or quality of life. One study reported that healing or cure time in the steroid group was slower than the placebo group (for every 100 people cured in the control group, only 47 were cured in the steroid group during the same time period), but the largest study did not report any difference (for every 100 people cured in the control group, 92 were cured in the steroid group during the same time interval). For adverse events, none of the studies found a difference between the two groups, except that one study reported that more eyes in the control group developed intraocular pressure (IOP) elevation. We did not find any information on economic outcomes. </p> <p><b>Quality of the evidence</b> </p> <p>Generally, the quality of the evidence based on the four studies we identified was moderate due to the proportions of participants who were not included in the final study analyses and the inconsistency of outcomes assessed across the four studies. In addition, three studies enrolled too few participants (30 to 42) to reach scientifically valid conclusions. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005430-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005430-sec-0088"></div> <h3 class="title" id="CD005430-sec-0089">Implications for practice</h3> <section id="CD005430-sec-0089"> <p>The effectiveness of corticosteroids as an adjunctive treatment for bacterial keratitis remains unknown at present. The completed randomized controlled trials (RCTs) are either inconclusive or have limitations when applied to other populations (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-SCUT-2012" target="_blank">SCUT 2012</a>). Two studies reported no benefit of topical steroids in regards to visual acuity, ulcer healing, and re‐epithelialization (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-Blair-2011" target="_blank">Blair 2011</a>; <a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-SCUT-2012" target="_blank">SCUT 2012</a>). None of the studies reported harmful effects of adding topical steroids to antibiotics in the treatment of bacterial corneal ulcers. The Steroids for Corneal Ulcers Trial (SCUT) investigators reported that steroids may be beneficial in some cases, such as central ulcers with severely decreased vision, based on a post hoc subgroup analysis. They also suggested that steroids may be contraindicated in the subgroup of patients that present with <i>Nocardia</i> keratitis. </p> <p>Although many currently recommend waiting at least 24 hours before instituting corticosteroid therapy, there is no evidence available that argues for or against immediate institution concurrent with antibiotic therapy. Identification of the bacterial pathogen is crucial for appropriate selection of antibiotics. Close observation for complications and wound healing is essential. </p> </section> <h3 class="title" id="CD005430-sec-0090">Implications for research</h3> <section id="CD005430-sec-0090"> <p>The studies included in this review have shown neither harm nor benefit from the use of adjunctive steroids together with antibiotics for the treatment of bacterial ulcers. Further, results have not been clear when dealing with severe bacterial keratitis where corneal scarring is of great concern. In addition, a majority of studies (3/4) were inadequately powered to detect a treatment effect. To demonstrate benefits and harms of adjunctive corticosteroid use larger studies, with severe corneal ulcer subgroups, are needed. With modern clinical imaging techniques, the assessment of ulcer severity as well as treatment results should be more reliable. Furthermore, all studies began the use of topical steroids after a minimum of 24 to 48 hours of exclusive antibiotic treatment. Therefore, the early treatment of ulcers with adjunctive steroids has yet to be studied. </p> <p>Any future trial should be designed with a target sample size calculated based on realistic assumptions regarding the effect size that could be expected based on currently available estimates of outcomes and likely follow‐up rates. In addition, strategies for assuring complete or nearly complete follow‐up of all randomized participants should be designed and implemented. The feasibility of such a trial requires careful evaluation. In addition, a future trial should also collect quality of life data and economic outcome data. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005430-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005430-sec-0022"></div> <section id="CD005430-sec-0023"> <h3 class="title" id="CD005430-sec-0023">Description of the condition</h3> <section id="CD005430-sec-0024"> <h4 class="title">Introduction</h4> <p>Keratitis, also known as corneal inflammation or corneal ulcers, is a potentially sight‐threatening condition that may have infectious or non‐infectious etiology. Keratitis presents as a diagnostic challenge due to the large number of possible causes that may lead to this condition. Bacterial keratitis is a serious ocular infectious disease that can lead to severe visual loss. Risk factors for bacterial corneal infection include contact lens wear, ocular surface disease, corneal trauma, and previous ocular or eyelid surgery. Certain ocular diseases and systemic conditions that depress the immune system also increase the possibility of bacterial keratitis. </p> </section> <section id="CD005430-sec-0025"> <h4 class="title">Epidemiology</h4> <p>Approximately 30,000 cases of microbial keratitis, which includes bacterial, fungal, and parasitic causes, are diagnosed annually in the United States (<a href="./references#CD005430-bbs2-0048" title="PeposeJS , WilhelmusKR . Divergent approaches to the management of corneal ulcers. American Journal of Ophthalmology1992;114(5):630‐2. ">Pepose 1992</a>). The proportion of people who develop corneal blindness secondary to bacterial keratitis is high in developing countries (<a href="./references#CD005430-bbs2-0027" title="ChiramboMC , TielschJM , WestKPJr , KatzJ , TizazuT , SchwabL , et al. Blindness and visual impairment in Southern Malawi. Bulletin of the World Health Organization1986;64(4):567‐72. ">Chirambo 1986</a>; <a href="./references#CD005430-bbs2-0030" title="FengCM . The causes of blindness by corneal diseases in 3499 cases. Chinese Journal of Eye Science [Zhonghua Yan Ke Za Zhi]1990;26(3):151‐3. ">Feng 1990</a>). The spectrum of bacterial keratitis also may be influenced by geographic and climate factors. Many differences in keratitis profile have been noted between populations living in rural or urban areas, in western or in developing countries (<a href="./references#CD005430-bbs2-0023" title="BakerRS , FlowersCWJr , CaseyR , FongDS , WilsonMR . Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Archives of Ophthalmology1996;114(5):632‐3. ">Baker 1996</a>; <a href="./references#CD005430-bbs2-0024" title="BennettHG , HayJ , KirknessCM , SealDV , DevonshireP . Antimicrobial management of presumed microbial keratitis: guidelines for the treatment of central and peripheral ulcers. British Journal of Ophthalmology1998;82(2):137‐45. ">Bennett 1998</a>; <a href="./references#CD005430-bbs2-0026" title="BurtonMJ , PithuwaJ , OkelloE , AfwambaI , OnyangoJJ , OatesF , et al. Microbial keratitis in East Africa: why are the outcomes so poor?. Ophthalmic Epidemiology2011;18(4):158‐63. ">Burton 2011</a>; <a href="./references#CD005430-bbs2-0037" title="KaliamurthyJ , KalavathyCM , ParmarP , Nelson JesudasanCA , ThomasPA . Spectrum of bacterial keratitis at a tertiary eye care centre in India. BioMed Research International2013:Article ID 181564. ">Kaliamurthy 2013</a>; <a href="./references#CD005430-bbs2-0051" title="SchaeferF , BruttinO , ZografosL , Guex‐CrosierY . Bacterial keratitis: a prospective clinical and microbiological study. British Journal of Ophthalmology2001;85(7):842‐7. ">Schaefer 2001</a>; <a href="./references#CD005430-bbs2-0054" title="VajpayeeRB , DadaT , SaxenaR , VajpayeeM , TaylorHR , VenkateshP , et al. Study of the first contact management profile of cases of infectious keratitis: a hospital‐based study. Cornea2000;19(1):52‐6. ">Vajpayee 2000</a>). </p> <p>Certain bacteria that make up the normal ocular flora are usually implicated in cases of infectious keratitis. Due to the proximity of these organisms to the cornea, they are easily inoculated into damaged or abnormal corneal tissues. Host defenses are usually sufficient to prevent infection but once these are violated, for example, in trauma or debilitating diseases, florid bacterial contamination of ocular tissue may occur. Common causative organisms include staphylococci and streptococci, inherent residents of the ocular milieu (<a href="./references#CD005430-bbs2-0041" title="Mino de KasparH , KossMJ , HeL , BlumenkranzMS , TaCN . Antibiotic susceptibility of preoperative normal conjunctival bacteria. American Journal of Ophthalmology2005;139(4):730‐3. ">Miño de Kaspar 2005</a>; <a href="./references#CD005430-bbs2-0042" title="MoellerCT , BrancoBC , YuMC , FarahME , SantosMA , Hofling‐LimaAL . Evaluation of normal ocular bacterial flora with two different culture media. Canadian Journal of Ophthalmology2005;40(4):448‐53. ">Moeller 2005</a>). In the past several years there has been an increase in the number of contact lens wearers (<a href="./references#CD005430-bbs2-0049" title="PoggioEC , GlynnRJ , ScheinOD , SeddonJM , ShannonMJ , ScardinoVA , et al. The incidence of ulcerative keratitis among users of daily‐wear and extended‐wear soft contact lenses. New England Journal of Medicine1989;321(12):779‐83. ">Poggio 1989</a>). The incidence of bacterial keratitis secondary to use of extended‐wear contact lenses is about 8000 cases per year. Multiple organisms have been isolated from cases of microbial keratitis in association with contact lens wear (<a href="./references#CD005430-bbs2-0040" title="LeeYS , TanHY , YehLK , LinHC , MaDH , ChenHC , et al. Pediatric microbial keratitis in Taiwan: clinical and microbiological profiles, 1998‐2002 versus 2008‐2012. American Journal of Ophthalmology2014;157(5):1090‐6. ">Lee 2014</a>; <a href="./references#CD005430-bbs2-0049" title="PoggioEC , GlynnRJ , ScheinOD , SeddonJM , ShannonMJ , ScardinoVA , et al. The incidence of ulcerative keratitis among users of daily‐wear and extended‐wear soft contact lenses. New England Journal of Medicine1989;321(12):779‐83. ">Poggio 1989</a>). A higher prevalence of gram‐negative rods, such as pseudomonas, was reported in contact lens wearers compared to patients who do not use contact lenses (<a href="./references#CD005430-bbs2-0028" title="DartJK , StapletonF , MinassianD . Contact lenses and other risk factors in microbial keratitis. Lancet1991;338(8768):650‐3. ">Dart 1991</a>; <a href="./references#CD005430-bbs2-0052" title="ScheinOD , OrmerodLD , BarraquerE , AlfonsoE , EganKM , PatonBG , et al. Microbiology of contact lens‐related keratitis. Cornea1989;8(4):281‐5. ">Schein 1989</a>). </p> <p>Conditions that disrupt ocular homeostasis may set the stage for bacterial contamination of the cornea. Agricultural workers, contact lens wearers, and patients who have received any form of ocular surgery or trauma all have increased risk of bacterial keratitis. Ocular surface disorders such as recurrent erosions and tear film abnormalities, lid abnormalities, and use and abuse of topical medications all predispose to infections. Debilitating diseases, immunocompromised states, and chronic use of immunosuppressive drugs also contribute to this disease condition (<a href="./references#CD005430-bbs2-0025" title="BourcierT , ThomasF , BorderieV , ChaumeilC , LarocheL . Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. British Journal of Ophthalmology2003;87(7):834‐8. ">Bourcier 2003</a>; <a href="./references#CD005430-bbs2-0038" title="KillingsworthDW , SternGA , DriebeWT , KnappA , DragonDM . Results of therapeutic penetrating keratoplasty. Ophthalmology1993;100(4):534‐41. ">Killingsworth 1993</a>; <a href="./references#CD005430-bbs2-0043" title="MuschDC , SugarA , MeyerRF . Demographic and predisposing factors in corneal ulceration. Archives of Ophthalmology1983;101(10):1545‐8. ">Musch 1983</a>). </p> </section> <section id="CD005430-sec-0026"> <h4 class="title">Presentation and diagnosis</h4> <p>Patients with bacterial keratitis present with unilateral and, in rare instances, bilateral, pain and abnormal sensitivity to light (photophobia). Corneal epithelial breaks that are associated with ulcers expose corneal nerve endings and contribute to the pain and discomfort that are associated with this condition. </p> <p>Typically, the anterior segment of the eye is inflamed and congested. Intense and diffuse conjunctival vessel injection is frequently observed. The discharge may be thick and profuse and is often mucoid to purulent in nature. The eyelids may be edematous and swollen and the underlying palpebral conjunctivae inflamed. The infected portion of the cornea usually contains a focal area of stromal infiltrate with an overlying area of epithelial excavation. The infiltrate is often, but not always, well circumscribed with distinct borders. The cornea is edematous and the visual acuity is reduced. The severity of visual loss is dependent on the extent and location of the lesion. </p> <p>Severe cases of bacterial keratitis lead to profound anterior chamber reaction and hypopyon (an accumulation of pus cells in the anterior chamber). Ciliary body inflammation sometimes causes hypotony (lower intraocular pressure); on the other hand, the presence of inflammatory cells in the aqueous may also clog the trabecular meshwork and increase the intraocular pressure. </p> <p>Determining the etiology of the keratitis by taking corneal scrapes and appropriate cultures is an essential step before the use of any topical antibiotic. However, empirical therapy need not be withheld until culture results become available. Unfortunately, there are no clear‐cut signs that point to a bacterial cause of the keratitis. Patient history and on examination the status of the epithelium, the size and time to diagnosis of the corneal lesions, the degree of the stromal inflammation, the quality and quantity of discharge, and other associated findings all have to be considered to arrive at a presumptive diagnosis. </p> <p>The yield from microbiological investigation may be low despite direct inoculation of a sample on the culture media. However, the positive culture will guide the ophthalmologist's choice of appropriate antibiotic therapy. </p> </section> </section> <section id="CD005430-sec-0027"> <h3 class="title" id="CD005430-sec-0027">Description of the intervention</h3> <p>Topical antibiotics constitute the mainstay of treatment in cases of bacterial keratitis, whereas the use of topical corticosteroids remains controversial. The role of topical corticosteroids as an adjunctive therapy for bacterial keratitis has been discussed in many studies. Topical steroids are usually given to control inflammation using the smallest possible amount of the drug. Their use requires optimal timing, concomitant antibiotics, and careful follow‐up. The effect of treatment on the viability of bacteria in the cornea, corneal wound healing, corneal scarring, increase in intraocular pressure, clinical outcomes, and adverse events warrants comparison between antibiotics alone and antibiotics plus corticosteroids. </p> <p>Topical fluoroquinolone antibiotics are popular choices for initial broad‐spectrum therapy (<a href="./references#CD005430-bbs2-0031" title="GangopadhyayN , DaniellM , WeihL , TaylorHR . Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. British Journal of Ophthalmology2000;84(4):378‐84. ">Gangopadhyay 2000</a>; <a href="./references#CD005430-bbs2-0035" title="HyndiukRA , EifermanRA , CaldwellDR , RosenwasserGO , SantosCI , KatzHR , et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin‐cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology1996;103(11):1854‐62. ">Hyndiuk 1996</a>; <a href="./references#CD005430-bbs2-0044" title="O'BrienTP , MaguireMG , FinkNE , AlfonsoE , McDonnellP . Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Archives of Ophthalmology1995;113(10):1257‐65. ">O'Brien 1995</a>; <a href="./references#CD005430-bbs2-0045" title="The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double‐masked, randomized, controlled trial with conventional dual therapy. Ophthalmology1997;104(11):1902‐9. ">OSG 1997</a>; <a href="./references#CD005430-bbs2-0046" title="ParksDJ , AbramsDA , SarfaraziFA , KatzHR . Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. American Journal of Ophthalmology1993;115(4):471‐7. ">Parks 1993</a>). However, resistance to these drugs may occur with some organisms (<a href="./references#CD005430-bbs2-0051" title="SchaeferF , BruttinO , ZografosL , Guex‐CrosierY . Bacterial keratitis: a prospective clinical and microbiological study. British Journal of Ophthalmology2001;85(7):842‐7. ">Schaefer 2001</a>). The new generation of fluoroquinolones, such as moxifloxacin and gatifloxacin, are currently gaining in popularity and these drugs show promise in the treatment of infectious corneal ulcers (<a href="./references#CD005430-bbs2-0036" title="HyonJY , JooMJ , HoseS , SinhaD , DickJD , O'BrienTP . Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Archives of Ophthalmology2004;122(8):1166‐9. ">Hyon 2004</a>; <a href="./references#CD005430-bbs2-0039" title="KowalskiRP , DhaliwalDK , KarenchakLM , RomanowskiEG , MahFS , RitterbandDC , et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin and ofloxacin using bacterial keratitis isolates. American Journal of Ophthalmology2003;136(3):500‐5. ">Kowalski 2003</a>). </p> <p>Dosing of the antibiotic is often dependent on the size of the ulcer and severity of keratitis. In severe cases, subconjunctival, subtenon, or intravenous antibiotics are instituted. Cycloplegic eyedrops may be given to reduce pain and inflammation. </p> <p>However, the role of topical corticosteroids as adjunctive therapy for bacterial keratitis is less clear. </p> </section> <section id="CD005430-sec-0028"> <h3 class="title" id="CD005430-sec-0028">How the intervention might work</h3> <p>Topical corticosteroids have consistently been avoided by many practitioners for fear of causing immunosuppression and, consequently, potentiating bacterial replication. Judicious use of steroids with adequate antibiotic therapy may, however, be beneficial for the patient. Once the micro‐organisms have been eliminated and adequate sterilization has been achieved, lessening the inflammatory response through corticosteroids may reduce corneal neovascularization and scarring. </p> </section> <section id="CD005430-sec-0029"> <h3 class="title" id="CD005430-sec-0029">Why it is important to do this review</h3> <p>Topical steroids are used to control damage from inflammation in bacterial keratitis. Although corticosteroids as an adjunctive therapy for bacterial keratitis have been discussed in many published reports, recommendations regarding the type and concentration of corticosteroid, frequency of dosing, optimal timing with respect to the introduction of topical antibiotics, and stage of healing are not consistent. A systematic review of available studies is needed to further understanding of the use of corticosteroids in treating bacterial keratitis and better define their role as an adjunctive treatment modality for bacterial corneal ulcers. </p> <p>This review is an update of a Cochrane review first published in 2007 (<a href="./references#CD005430-bbs2-0056" title="Suwan‐ApichonO , ReyesJM , HerretesS , VedulaSS , ChuckRS . Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005430.pub2] ">Suwan‐apichon 2007</a>), where there was only one trial published for the use of topical steroid for keratitis (<a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>). Over recent years, several additional trials have been conducted and investigated the effectiveness and safety of keratitis (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>; <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>; <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>), and we included these trials in the data synthesis for this review. The protocol for the review was published in 2005 (<a href="./references#CD005430-bbs2-0055" title="Suwan‐apichonO , ReyesJM , ChuckRS , HerretesS , VedulaSS . Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD005430] ">Suwan‐apichon 2005</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005430-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005430-sec-0030"></div> <p>The objective of the review was to assess the effectiveness and safety of corticosteroids as adjunctive therapy for bacterial keratitis. Secondary objectives included evaluation of health economic outcomes and quality of life outcomes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005430-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005430-sec-0031"></div> <section id="CD005430-sec-0032"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005430-sec-0033"> <h4 class="title">Types of studies</h4> <p>We included all relevant randomized controlled trials (RCTs) in this review.</p> </section> <section id="CD005430-sec-0034"> <h4 class="title">Types of participants</h4> <p>We included studies in which participants were diagnosed to have bacterial keratitis either clinically or microbiologically. We excluded studies that included participants who had mixed infections and corneal perforations that warranted surgical intervention. </p> </section> <section id="CD005430-sec-0035"> <h4 class="title">Types of interventions</h4> <p>We included studies using topical corticosteroids as an adjunct to antibiotics in the management of bacterial keratitis. Eligible studies included placebo‐controlled trials and trials that compared different steroids against each other as adjunctive agents. </p> </section> <section id="CD005430-sec-0036"> <h4 class="title">Types of outcome measures</h4> <section id="CD005430-sec-0037"> <h5 class="title">Primary outcomes</h5> <p>The primary outcomes for comparison of the treatments were:</p> <p> <ol id="CD005430-list-0001"> <li> <p>clinical improvement, defined as lessening of the ocular inflammation, congestion, pain, photophobia, and overall ocular discomfort; improvement in corneal clarity and visual acuity (i.e. best corrected visual acuity, BCVA), decrease in size of infiltrate and epithelial defect; </p> </li> <li> <p>clinical cure, defined as complete healing (re‐epithelialization) of the epithelium with scarring, disappearance of any sign of inflammation such as congestion and anterior chamber cellular reaction. </p> </li> </ol> </p> <p>We reported the primary outcome at different times of follow‐up, as described in the included studies. </p> </section> <section id="CD005430-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p>The secondary outcomes for comparison of the treatments were:</p> <p> <ol id="CD005430-list-0002"> <li> <p>microbiologic cure, defined as sterilization of the cornea and absence of bacterial viability as shown by corneal smears and cultures; </p> </li> <li> <p>time to clinical or microbiologic cure.</p> </li> </ol> </p> <p>We planned to report the outcomes at different times of follow‐up, as described in the included studies. </p> <section id="CD005430-sec-0039"> <h6 class="title">Adverse effects</h6> <p>Adverse effects of interest included:</p> <p> <ol id="CD005430-list-0003"> <li> <p>persistence and progression of the corneal infection, defined as increasing infiltrate size and/or bacterial colony count in smear or culture‐positive isolates; </p> </li> <li> <p>corneal melting, descemetocele formation, and perforation;</p> </li> <li> <p>endophthalmitis;</p> </li> <li> <p>increased intraocular pressure, steroid‐induced or inflammatory glaucoma;</p> </li> <li> <p>ocular surface complications and allergic reactions attributable to the steroid application alone or to the combination of medications used; </p> </li> <li> <p>recurrence of the corneal ulcer. This can happen at any time after the first ulcer, sometimes years later, so we recorded what was reported in the included studies. </p> </li> </ol> </p> <p>We summarized adverse effects related to topical corticosteroid therapy reported in all included studies. However, we recognize the difficulty of differentiating between adverse effects of corticosteroid therapy and adverse outcomes of the progressive infections being treated with antibiotics. </p> </section> <section id="CD005430-sec-0040"> <h6 class="title">Quality of life measures</h6> <p>We have described the quality of life findings reported in included studies.</p> </section> <section id="CD005430-sec-0041"> <h6 class="title">Economic data</h6> <p>We will report the cost of adding steroids to the therapeutic regimen as assessed in any future trial(s) in updates of this review. No such data had been reported in the included studies. </p> </section> <section id="CD005430-sec-0042"> <h6 class="title">Follow‐up</h6> <p>To take into account the possibility of recurrence, we only included studies with at least one‐month follow‐up for analysis. </p> </section> </section> </section> </section> <section id="CD005430-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005430-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2014, Issue 6), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to July 2014), EMBASE (January 1980 to July 2014), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to July 2014), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 14 July 2014. </p> <p>See: Appendices for details of search strategies for CENTRAL (<a href="./appendices#CD005430-sec-0094">Appendix 1</a>), MEDLINE (<a href="./appendices#CD005430-sec-0095">Appendix 2</a>), EMBASE (<a href="./appendices#CD005430-sec-0096">Appendix 3</a>), LILACS (<a href="./appendices#CD005430-sec-0096">Appendix 3</a>), <i>m</i>RCT (<a href="./appendices#CD005430-sec-0098">Appendix 5</a>), ClinicalTrials.gov (<a href="./appendices#CD005430-sec-0099">Appendix 6</a>) and the ICTRP (<a href="./appendices#CD005430-sec-0100">Appendix 7</a>). </p> </section> <section id="CD005430-sec-0045"> <h4 class="title">Searching other resources</h4> <p>We identified and screened through all reports that had cited the only trial included in the original version of this review using the Science Citation Index database. We screened the reference lists of newly included studies and earlier reviews, including <a href="./references#CD005430-bbs2-0018" title="WilhelmusKR . Indecision about corticosteroids for bacterial keratitis: an evidence‐based update. Ophthalmology2002;109(5):835‐42. ">Wilhelmus 2002</a>, and abstracts from the American Academy of Ophthalmology meeting in 2003 (<a href="./references#CD005430-bbs2-0021" title="American Academy ofOphthalmology . American Academy of Ophthalmology Final Program (conference abstracts), Chicago. San Francisco, USA: American Academy of Ophthalmology, 2003. ">AAO 2003</a>), to identify additional relevant studies. We did not handsearch any journals or conference proceedings specifically for this review as they are searched routinely by the Cochrane Eyes and Vision Group and added to the CENTRAL database. </p> </section> </section> <section id="CD005430-sec-0046"> <h3 class="title" id="CD005430-sec-0046">Data collection and analysis</h3> <section id="CD005430-sec-0047"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently reviewed the titles and abstracts resulting from the literature searches, according to the inclusion criteria. We classified the titles and abstracts as 'definitely relevant', 'possibly relevant', or 'definitely irrelevant', and resolved disagreement by discussions. After reaching a consensus, we retrieved the full text for articles in the 'definitely relevant' or 'possibly relevant' categories and re‐assessed the eligibility. We then labeled articles as 'include' or 'exclude', and resolved disagreements through discussion. For any unclear information, we requested additional information from the study investigators and allowed two weeks for them to respond. When they did not respond within two weeks, we used the information as available. We excluded full‐text articles labeled as 'exclude', and documented the studies, along with reasons for exclusion, in the '<a href="./references#CD005430-sec-0110" title="">Characteristics of excluded studies</a>' table. </p> </section> <section id="CD005430-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data on study characteristics and outcomes listed in the '<a href="#CD005430-sec-0032">Criteria for considering studies for this review</a>' from the published reports of included studies using data extraction forms developed for this purpose. We resolved discrepancies through discussion. We contacted primary investigators of the studies for missing or unreported data. When they did not respond within two weeks, we used the information available. One review author entered the data into Review Manager 5.3 (<a href="./references#CD005430-bbs2-0050" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and a second review author verified the data entry. </p> </section> <section id="CD005430-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed the included studies for risk of bias according to guidelines set out in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005430-bbs2-0033" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). We assessed each domain as 'low risk', 'high risk', or 'unclear' risk of bias. We considered methods employed to address the following risks of bias to determine the methodological quality of included studies: </p> <p> <ul id="CD005430-list-0004"> <li> <p>Selection bias: we assessed random sequence generation and allocation concealment before randomization. Any method of allocation concealment, such as centralized randomization or use of sequential, opaque envelopes, which provided reasonable confidence that the allocation sequence was concealed from participating physicians and patients was to be considered 'low risk'. We assessed trial reports without such explicit mention of a method of allocation concealment for convincing information on adequacy of allocation concealment. Whenever the adequacy of allocation concealment was unclear from the trial report, we contacted the primary investigators for clarification. If they did not respond within a two‐week time period, we classified the studies based on available information and will update our classifications when more information becomes available. </p> </li> <li> <p>Performance bias: we assessed masking of participants and care providers with regard to treatment allocation. </p> </li> <li> <p>Detection bias: we assessed masking of outcome assessors with regard to treatment allocation. </p> </li> <li> <p>Attrition bias: we assessed whether rates of follow‐up and reasons for loss to follow‐up for intervention and control arms were similar and whether all participants were analyzed in the group to which they were randomized. We also examined whether both participants for whom no outcome was collected, and those who received only some or none of their allotted treatment, were included in the analysis. We interpreted the analysis as intention‐to‐treat only when both the above criteria were fulfilled. We assessed studies following an intention‐to‐treat analysis as having 'low risk' of attrition bias. </p> </li> <li> <p>Reporting bias: we considered studies that had reported all outcomes as specified in a protocol, clinical trial registry, or in the methods section of the published report as having 'low risk' of reporting bias. </p> </li> </ul> </p> <p>We resolved disagreements through discussion. We contacted the authors of included studies for additional information on issues that we categorized as 'unclear' from information available in the trial reports. Whenever they did not respond within a two‐week time period, we assessed the studies based on available information and will update our assessments when more information becomes available. </p> </section> <section id="CD005430-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We reported a summary risk ratio (RR) for dichotomous outcomes (adverse events) when data were available. For continuous data (BCVA), we calculated the mean difference and 95% confidence interval between two intervention groups when sufficient data were provided. We reported time‐to‐event data (time to re‐epithelialization) as a summary log hazard ratio using methods described in <a href="./references#CD005430-bbs2-0047" title="ParmarMKB , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a> to extract information on observed and log‐rank expected events from the included studies. </p> </section> <section id="CD005430-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis for this review was the eye or the person, because all four studies included one eye per participant. For future studies including both eyes, where one eye is allocated to one intervention group and the other eye is allocated to the other intervention group, we will consider intra‐person correlation when conducting the analysis, and refer to the principles outlined in Chapter 16 of the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005430-bbs2-0034" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>). </p> </section> <section id="CD005430-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study investigators whenever there was missing or unclear information. When they did not respond within two weeks, we proceeded with available data. </p> </section> <section id="CD005430-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>We evaluated clinical and methodological heterogeneity in terms of study characteristics, participant inclusion/exclusion criteria, and primary and secondary outcomes. We assessed statistical heterogeneity using summary test statistics (I<sup>2</sup> statistic). When the I<sup>2</sup> statistic was greater than or equal to 50%, we also examined the Chi<sup>2</sup> statistic for heterogeneity, the degree of overlap in confidence intervals, and the directions of treatment effect of included studies. Poor overlap suggests the presence of heterogeneity. </p> </section> <section id="CD005430-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>For selective outcome reporting, we assessed the bias by comparing the protocols of the study and the published final report(s). We also compared the outcomes specified in the Methods section and reported in the Results section to identify potential selective outcome reporting. For future updates of the review, when there are at least 10 studies included in a meta‐analysis, we will examine the symmetry of the funnel plot for the meta‐analysis in order to assess the potential for publication bias. </p> </section> <section id="CD005430-sec-0055"> <h4 class="title">Data synthesis</h4> <p>We conducted data analysis according to the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 9 (<a href="./references#CD005430-bbs2-0029" title="DeeksJJ , HigginsJPT , AltmanDG , editors. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). In future updates of the review, we plan to assess the inconsistency of effect estimates across studies using the I<sup>2</sup> statistic when sufficient data are available. Our a priori decision was not to combine the outcomes from multiple studies in a meta‐analysis in the presence of substantial heterogeneity, i.e. an I<sup>2</sup> statistic greater than 50%. In the absence of substantial statistical and clinical heterogeneity, we combined the results of included studies using a random‐effects model. We plan to use a fixed‐effect model whenever fewer than three studies contribute data to a meta‐analysis. </p> </section> <section id="CD005430-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct subgroup analysis based on the causative organism. As there was only one article with such information, reporting the <i>Nocardia</i> species, we provided descriptive summaries of those findings. </p> </section> <section id="CD005430-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses to assess how robust the review results are to key decisions and assumptions made during the review. We will conduct sensitivity analyses of data in updates of this review with the following adjustments when a sufficient number of studies can be included: </p> <p> <ol id="CD005430-list-0005"> <li> <p>exclusion of studies with high risk of bias, specifically for loss of follow‐up and selective outcome reporting; </p> </li> <li> <p>exclusion of unpublished studies.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005430-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005430-sec-0058"></div> <section id="CD005430-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD005430-sec-0060"> <h4 class="title">Results of the search</h4> <p>The initial electronic searches returned 336 titles and abstracts as of 15 January 2007. We screened the titles and abstracts of these records and judged 16 to be potentially relevant. On review of full‐text reports, we included one trial in the original review and excluded the remaining 15 studies. </p> <p>Updated searches conducted as of 14 July 2014 yielded a total of 562 titles and abstracts and six records from <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>. We screened the records and judged 19 titles and abstracts and two records from <a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a> to be potentially relevant. Upon retrieving full‐text reports and assessing the eligibility for each study, we found three studies that met our inclusion criteria, among which one trial was a pilot study (<a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>) of another large trial (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>); 16 reports emanated from the same large trial (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>) and two reports from another trial (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-Blair-2011" target="_blank">Blair 2011</a>). For the two records from <a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>, one trial already had been included in our review (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>); we recorded the characteristics of the other trial in the '<a href="./references#CD005430-sec-0111" title="">Characteristics of ongoing studies</a>' table. The search and selection flow diagram is shown in <a href="#CD005430-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD005430-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Results from searching for studies for inclusion in the review" data-id="CD005430-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review</p> </div> </div> </div> </section> <section id="CD005430-sec-0061"> <h4 class="title">Included studies</h4> <p>We included four studies, summarized below. Further details are recorded in the '<a href="./references#CD005430-sec-0109" title="">Characteristics of included studies</a>' table. </p> <section id="CD005430-sec-0062"> <h5 class="title">Types of participants</h5> <p>The four studies included a total of 612 eyes of 611 participants. The largest trial had 500 eligible participants and eyes (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-SCUT-2012" target="_blank">SCUT 2012</a>). The other three studies enrolled 30 to 58 participants. All participants in the included studies were aged 12 years or older at time of presentation with corneal ulcers. One study was conducted in South Africa and randomized 40 eyes of 39 participants (<a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>). <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> was a pilot study of <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> (the Steroids for Corneal Ulcers Trial, SCUT). The pilot study investigators enrolled 42 participants from 4 January 2005 to 20 August 2005 at a single center in India. <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> enrolled 500 participants from 1 September 2006 to 22 February 2010 from multiple centers across India and the United States. The fourth study was conducted in Canada and the investigators enrolled 30 eyes of 30 participants (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>). </p> </section> <section id="CD005430-sec-0063"> <h5 class="title">Types of interventions</h5> <p>All four studies included topical corticosteroid as an adjunctive therapy to antibiotics in one arm and compared it with antibiotics only in the other arm. Each of the studies used slightly different drugs and concentrations as described below: </p> <p><a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> compared corticosteroid (0.1% dexamethasone) plus antibiotics (cefazolin, fortified, 32 g/l, and gentamicin, fortified, 14 g/l) or placebo (0.9% sodium chloride) plus antibiotics. </p> <p>Both the pilot study (<a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>) and SCUT (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>) compared 1% topical prednisolone phosphate or placebo (0.9% sodium chloride) in adjunct to antibiotics. All participants received a minimum of 48 hours of topical moxifloxacin treatment before randomization and continued to receive the drug every two hours until re‐epithelialization and then four times a day until three weeks after enrollment. </p> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> compared an antibiotic‐only group (gatifloxacin and placebo) with an antibiotic‐steroid group (gatifloxacin and 0.1% dexamethasone). </p> </section> <section id="CD005430-sec-0064"> <h5 class="title">Types of outcomes</h5> <p>All four studies reported visual acuity, healing rate, ulcer size, or time to re‐epithelialization. However, each of them reported data at different time points, or used different methods for data analysis. A comparison across studies is listed in <a href="#CD005430-tbl-0001">Table 1</a>. </p> <div class="table" id="CD005430-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Clinical outcomes reported in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><b>Visual acuity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect measure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean change in logMAR visual acuity from baseline, measured by ETDRS chart</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean BCVA from Snellen chart and then converted to a numerical equivalent number; linear regression model </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference in logMAR BCVA between groups from multiple linear regression model, using a protocol adapted from AREDS using a tumbling "E" chart </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean logMAR BCVA adapted from AREDS using a tumbling "E" chart; mean difference in logMAR BCVA between groups from multiple linear regression model </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time point(s) measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks, 3 months, 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks and 3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Steroid group: ‐0.31 (SD or 95% CI not reported)</p> <p>Control group: ‐0.18 (SD or 95% CI not reported)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1) Mean BCVA:</p> <p>Steroid group: mean pretreatment vision: 6; mean post‐treatment vision: 9.7</p> <p>Non‐steroid group: mean pretreatment vision: 6.4; mean post‐treatment vision: 9.2</p> <p>2) Linear regression model: linear regression showed no difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks: steroid group had 0.024 better logMAR BCVA (95% CI ‐0.092 to 0.044)</p> <p>3 months: steroid group had 0.009 better logMAR BCVA (95% CI ‐0.085 to 0.068)</p> <p>12 months: steroid group had 0.04 better logMAR BCVA (95% CI ‐0.12 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1) Mean (SD) logMAR BCVA:</p> <p>3 weeks: steroid group: 0.66 (0.68); placebo group: 0.75 (0.75)</p> <p>3 months: steroid group: 0.71 (0.72); placebo group: 0.59 (0.75)</p> <p>2) Multiple linear regression model:</p> <p>3 weeks: steroid group had 0.19 lower (better) logMAR BCVA (95% CI ‐0.52 to 0.15)</p> <p>3 months: steroid group had 0.09 lower (better) logMAR BCVA (95% CI ‐0.41 to 0.24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interpretation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><b>Healing rate/ulcer size</b> </p> <p><b>/time to re‐epithelialization</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect measure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean change in ulcer area from baseline (mm<sup>2</sup>), measured by photographic measurement and by clinician estimate (slit lamp) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean size of ulcer (mm<sup>2</sup>) healed per day, measured at the slit lamp </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference in diameter of ulcer area from linear regression models, measured by a Haag‐Streit 900 slit lamp biomicroscope; median time to re‐epithelialization (days) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference in diameter of ulcer area from linear regression models, measured by a Haag‐Streit 900 slit lamp biomicroscope </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time point(s) measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks, 3 months, 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks and 3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Photographic measurement:</p> <p>Steroid group: ‐4.388 mm<sup>2</sup> </p> <p>Control group: ‐1.919 mm<sup>2</sup> </p> <p>(SD or 95% CI not reported)</p> <p>Clinician estimate (slit lamp):</p> <p>Steroid group: ‐4.206 mm<sup>2</sup> </p> <p>Control group: ‐0.789 mm<sup>2</sup> </p> <p>(SD or 95% CI not reported)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Steroid group: 0.36 mm<sup>2</sup> per day </p> <p>Control group: 0.30 mm<sup>2</sup> per day </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer size:</p> <p>3 weeks: steroid group had 0.05 mm smaller diameter of scar area (95% CI ‐0.09 to 0.15) </p> <p>3 months: steroid group had 0.06 mm smaller diameter of scar area (95% CI ‐0.07 to 0.17) </p> <p>12 months: steroid group had 0.03 mm smaller diameter of scar area (95% CI ‐0.12 to 0.18) </p> <p>Time to re‐epithelialization:</p> <p>Steroid group: 7.5 days (95% CI 5.5 to 8.5 days)</p> <p>Placebo group: 7 days (95% CI 5.5 to 8.5 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer size:</p> <p>3 weeks: steroid group had 0.57 mm smaller diameter of scar area (95% CI 1.5 to 0.37)</p> <p>3 months: steroid group had 0.33 mm smaller diameter of scar area (95% CI 1.4 to 0.75)</p> <p>Time to re‐epithelialization:</p> <p>steroid group: 8.6 days (SD 4.7)</p> <p>placebo group: 6.3 days (SD 3.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interpretation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups from photographic measurement;</p> <p>statistically significant difference between groups from clinician estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>AREDS: Age Related Eye Disease Study<br/> BCVA: best corrected visual acuity<br/> CI: confidence interval<br/> ETDRS: Early Treatment Diabetic Retinopathy Study<br/> SD: standard deviation </p> </div> </div> <p>The study investigators of <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> measured healing rates and visual acuity in the two groups, with follow‐up time at a minimum of four weeks. </p> <p>The primary outcome for both the pilot study (<a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>) and the SCUT (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>) was BCVA at three months from enrollment. BCVA was measured using a tumbling E chart. Secondary outcomes included BCVA at three weeks, infiltrate/scar size at three weeks and three months measured by slit lamp examination, adverse events, and time to re‐epithelialization. The SCUT investigators followed participants for 12 months. At 12 months, 399 out of the initial 500 patients enrolled returned for a follow‐up examination (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). At this time point, the outcomes examined were BCVA and scar size. </p> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> reported measurements included ulcer size, visual acuity, time to healing, and quality of life at 10 weeks follow‐up. </p> </section> <section id="CD005430-sec-0065"> <h5 class="title">Funding sources</h5> <p>Funding sources for <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> were not reported. </p> <p>The SCUT (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>) was funded by the National Eye Institute and the pilot study (<a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>) was funded by That Man May See, the South Asia Research Fund, and the National Eye Institute. </p> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> was funded by the Physicians' Services Incorporation Foundation. </p> </section> </section> <section id="CD005430-sec-0066"> <h4 class="title">Excluded studies</h4> <p>Excluded studies along with reasons for exclusions are listed in the '<a href="./references#CD005430-sec-0110" title="">Characteristics of excluded studies</a>' table. </p> </section> </section> <section id="CD005430-sec-0067"> <h3 class="title">Risk of bias in included studies</h3> <p>Individually, the studies included in this review were at low risk of bias, except for <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>, which was at high or unclear risk of bias for five of the seven domains. Overall, all studies were high risk of attrition bias. The results of the 'Risk of bias' assessments are given in the '<a href="./references#CD005430-sec-0109" title="">Characteristics of included studies</a>' table and <a href="#CD005430-fig-0002">Figure 2</a>. A descriptive summary of studies included in this review is given below. </p> <div class="figure" id="CD005430-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005430-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD005430-sec-0068"> <h4 class="title">Allocation</h4> <p>The method for randomization was adequately addressed in all four included studies. <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> used a random numbers table. <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> used block randomization with block of 10 generated by RAND command in Excel. <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> used stratification and block randomization with blocks of six. Randomization was stratified by ulcer size in this study, as ulcer size is believed to be an important confounder. <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> used permuted blocks within study centers. Random block sizes were four, six, and eight. </p> <p>Allocation was concealed before randomization only in <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>; the allocation schedule was generated at a central office using a computer algorithm from the uniform distribution (STATA Corp, College Station, Tex.). The generator of the random allocation did not participate in executing the intervention and the executors did not participate in generating the schedule. </p> <section id="CD005430-sec-0069"> <h5 class="title">Masking (performance bias and detection bias)</h5> <p>For <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>, neither the participants nor the physicians caring for them were masked to the treatment allocation. Outcomes were assessed independently by two physicians, but neither was masked to the treatment allocation. Masking of participants and investigators was achieved in the other three studies. </p> </section> </section> <section id="CD005430-sec-0070"> <h4 class="title">Incomplete outcome data</h4> <p>Losses to follow‐up were common in all studies. <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> reported healing rates for only 26/40 (65%) eyes and visual acuity for only 28/40 (70%) eyes in the final analysis. Participants were excluded due to adverse events such as persistent epithelial defects and corneal thinning. <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> reported 26/30 (87%) eyes in the final analysis, where there was one participant (6.7%) missing for the antibiotic‐only group and three participants (20%) missing for the antibiotic‐steroid group. <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> reported 33/42 (79%) eyes and <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> reported 442/500 (88%) eyes in the final analysis. The reasons for loss to follow‐up were not reported for any of the latter three studies. Therefore, we judged all four studies to have high risk of attrition bias. </p> </section> <section id="CD005430-sec-0071"> <h4 class="title">Selective reporting</h4> <p>The risk of reporting bias for <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> and <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> was unclear because protocols were not available for these studies. The SCUT trial had reported all outcomes pre‐specified in the protocol (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). The protocol for <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> was not available, but because this is a pilot trial of the SCUT, we compared the two studies as well as the outcomes specified in the methods section and reported in the results sections for <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>, and we found the outcomes reported in these two studies to be the same. <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> had reported all outcomes specified in the methods section, so we considered <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> to be at low risk of outcome reporting bias. </p> </section> <section id="CD005430-sec-0072"> <h4 class="title">Other potential sources of bias</h4> <p>We did not identify any other potential source of bias among the included studies.</p> </section> </section> <section id="CD005430-sec-0073"> <h3 class="title" id="CD005430-sec-0073">Effects of interventions</h3> <p>Although different corticosteroids and different antibiotics were used in these four studies, all studies compared antibiotic treatment with versus without corticosteroids. Three studies performed a sample size calculation (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>; <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>; <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>). <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> estimated that 54 participants (27 participants per arm) would provide 80% power to detect a 4 mm<sup>2</sup> difference in ulcer size between groups, with a standard deviation (SD) of 3.3 mm. However, the required sample size was not achieved. <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> reported that 42 participants (21 participants per arm) would provide 80% power to detect a 0.4 logMAR (four Snellen lines) difference between the two study arms, assuming a SD of 0.4 in the three‐month best corrected visual acuity (BCVA); however, due to losses to follow‐up, the power was not maintained through the three‐month follow‐up examination. <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> investigators estimated that a sample size of 500 participants (250 per arm) would provide 80% power to detect a 0.20 logMAR (two lines of visual acuity) difference between groups in BCVA three months after enrollment, assuming a SD of 0.65 logMAR for three‐month BCVA. The calculation assumed a 20% dropout rate by three months. Only the Steroids for Corneal Ulcers Trial (SCUT) trial had a sample size large enough to detect or rule out an important between‐group difference (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). However, even SCUT was not powered to detect or rule out a difference between management approaches within causative organism‐specific subgroups. </p> <p>A summary table is shown in <a href="#CD005430-tbl-0001">Table 1</a>. We also describe the details below: </p> <section id="CD005430-sec-0074"> <h4 class="title">Primary outcomes (clinical improvement and clinical cure)</h4> <p>For primary outcomes of clinical improvement and clinical cure, the four studies reported data from a total of 529 eyes. Time to re‐epithelialization was reported by two studies, but all other outcomes were reported in different ways that precluded quantitative synthesis of the data. </p> <section id="CD005430-sec-0075"> <h5 class="title">Visual acuity</h5> <p>The four studies reported visual acuity at the last follow‐up (ranged from 2 months to 12 months) for 486 eyes. The four studies reported visual acuity measured in different ways and at different time points. In one study, best corrected visual acuity (BCVA) was measured on a Snellen chart at different times, then converted to author‐defined integer numbers ranging from 2 to 13, and fitted to a line for each participant using a linear regression model (<a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>). In another study, baseline, three‐week, and three‐month logMAR best corrected visual acuity (BCVA) was reported (<a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>). In the third study, the investigators reported change of logMAR visual acuity (VA) from baseline to 10 weeks (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>). The investigators of the largest trial also reported visual acuity change using a linear regression model (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). Therefore, we were unable to combine the visual acuity outcome data. However, none of the studies reported a significant difference in visual acuity between the treatment groups. A descriptive summary is below: </p> <p>The original data for <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> could not be located by the primary investigator. <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> reported 28 eyes for best corrected visual acuity at two months, and that there was no significant difference between the two groups from the regression model. </p> <p><a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> reported logMAR BCVA in 33 eyes of 33 participants at three weeks and three months. In the placebo group, the mean BCVA at enrollment was 1.15 logMAR (SD 0.63); it improved to 0.75 logMAR (SD 0.75) at three weeks and 0.59 logMAR (SD 0.75) at three months. In the steroid‐treated group, the mean enrollment visual acuity was 1.28 logMAR (SD 0.54); it improved to 0.66 logMAR (SD 0.68) at three weeks and 0.71 logMAR (SD 0.72) at three months. The baseline BCVA between the two groups was judged to be comparable by the authors of the study report (mean difference (MD) ‐0.13; 95% confidence interval (CI) ‐0.48 to 0.22; P value = 0.48). They concluded that, compared to placebo treatment, steroid treatment resulted in 0.19 lower (better) logMAR visual acuity (1.9 lines) at three weeks (95% CI 20.52 to 0.15, P value = 0.26) and 0.09 lower logMAR visual acuity (0.9 line) at three months (95% CI 20.41 to 0.24, P value = 0.60). </p> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> reported that the mean change of logMAR visual acuity in 26 eyes of 26 participants at 10 weeks was less in the antibiotic alone group than that in the steroid plus antibiotic group (MD 0.42; 95% CI not available; P value = 0.52). </p> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> reported results from 442 eyes of 442 participants at three months, and 399 eyes of 399 participants at 12 months. Based on a multiple linear regression analysis, the authors concluded that corticosteroids offered no significant improvement compared with placebo with respect to three‐month and 12‐month BCVA after controlling for enrollment BCVA: change from baseline to three‐month follow‐up (MD ‐0.009 logMAR; 95% CI ‐0.085 to 0.068; P value = 0.82); change from baseline to 12‐month follow‐up (MD ‐0.04 logMAR; 95% CI ‐0.12 to 0.05; P value = 0.39). </p> </section> <section id="CD005430-sec-0076"> <h5 class="title">Healing rate/ulcer size/time to re‐epithelialization</h5> <p>Clinical cure of corneal ulcers was assessed either by quantification of the size of the ulcer or the scar (by the clinician at the slit lamp or by photography) and by evaluating the size of the epithelial defect in order to determine closure or healing of the corneal epithelium. Two studies reported healing rates in 52 eyes (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>; <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>). <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> reported similar healing rates: 0.36 mm<sup>2</sup> per day in the corticosteroid group and 0.30 mm<sup>2</sup> per day in the control group; the difference was neither clinically nor statistically significant. The Kaplan–Meier analysis of time to healing used in <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> showed no difference in healing rates between the two groups: median healing time was eight weeks in the antibiotic‐only group versus six weeks in the antibiotic–steroid group (data not available). </p> <p>Three studies reported ulcer size at the last follow‐up examination in a total of 458 eyes (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>; <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>; <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>). <a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> measured ulcer size from photographs; the mean difference in change from baseline in the antibiotic group was less than in the steroid group (‐1.919 mm<sup>2</sup> in the antibiotic‐only group versus ‐4.388 mm<sup>2</sup> in the antibiotic‐steroid group; P value = 0.56) at 10 weeks. However, mean residual ulcer size at 10 weeks estimated by the clinician at the slit lamp differed between the two groups (‐0.789 mm<sup>2</sup> for the antibiotic‐only group and ‐4.206 mm<sup>2</sup> for the antibiotic‐steroid group; P value = 0.05). </p> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> reported that corticosteroid use was not associated with a difference in infiltrate/scar size at three weeks (MD 0.05 mm<sup>2</sup>; 95% CI –0.09 to 0.15, P value = 0.60), three months (MD 0.06 mm<sup>2</sup>; 95% CI ‐0.07 to 0.17, P value = 0.40), or one year (MD 0.03 mm<sup>2</sup>; 95% CI ‐0.12 to 0.18; P value = 0.69). <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> reported that steroid treatment was associated with somewhat smaller infiltrate/scar diameter compared with the placebo group at three weeks and three months (differences not available; P value = 0.23 and P value = 0.53 for three weeks and three months respectively). </p> <p>In two studies, clinical cure ("healing time" or "cure rate") was defined by re‐epithelialization at the last follow‐up examination; 432 eyes contributed to analysis of this outcome (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>; <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a>). <a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> reported that the median time to re‐epithelialization was 7.0 days (95% CI 5.5 to 8.5 days) in the placebo arm and 7.5 days (95% CI 5.5 to 8.5 days; P value = 0.25) in the corticosteroid arm (hazard ratio 0.92; 95% CI 0.76 to 1.12; P value = 0.44). <a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> reported that the average time to re‐epithelialization was 6.3 (SD 3.1) days in the placebo group and 8.6 (SD 4.7) days in the steroid‐treated patients; after adjusting for baseline epithelial defect size, the hazard ratio was 0.47 (95% CI 0.23 to 0.94, P value = 0.03). The heterogeneity was high (I<sup>2</sup> &gt; 50% and there was poor overlap of confidence intervals on individual estimates), therefore we present the data from the two studies in the forest plot without a pooled analysis (<a href="./references#CD005430-fig-0003" title="">Analysis 1.1</a>). Given that these two studies have the same inclusion/exclusion criteria for participants, such a high heterogeneity might be due to the differences in baseline characteristics of the participants, such as ulcer size/location/depth (lacking these data for the pilot study), organisms distribution, and population origins (India versus India and the USA). </p> </section> </section> <section id="CD005430-sec-0077"> <h4 class="title">Secondary outcomes (microbiologic cure and time to clinical or microbiologic cure)</h4> <p>No studies reported microbiologic cure and time to clinical or microbiologic cure outcomes as listed in the methods section of the review. </p> </section> <section id="CD005430-sec-0078"> <h4 class="title">Adverse effects</h4> <p>Four studies, including 612 eyes of 611 participants, contributed data for adverse effects (<a href="#CD005430-tbl-0002">Table 2</a>). </p> <div class="table" id="CD005430-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse events reported in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of the ulcer</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60 (0.12 to 58.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45 (0.04 to 4.60)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Second ulcer</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29 (0.01 to 6.50)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Corneal thinning</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.06 to 13.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.14)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Corneal perforation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.06 to 13.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.88 (0.32 to 2.38)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 3.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled infection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18 (0.01 to 3.56)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent epithelial defect</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.21 (0.31 to 4.71)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.63 (1.04 to 2.54)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epithelial breakdown</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.06 to 13.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.40 (0.45 to 4.35)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic infection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.00 (0.12 to 73.29)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in hypopyon</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (0.25 to 3.95)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IOP elevation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.04 to 0.90)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37 (0.02 to 8.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Worsening infiltrate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.25 (0.70 to 7.21)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37 (0.02 to 8.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.30 to 1.59)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval<br/> IOP: intraocular pressure<br/> RR: risk ratio </p> </div> </div> <p><a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> reported that one eye in each group experienced perforation, corneal thinning, and epithelial breakdown (breakdown of epithelium after initial healing). Two eyes in the control group had uncontrolled infection. Recurrence of infection (recurrence of hypopyon within one week of discharge after adequate treatment of infection) occurred in one eye in the corticosteroid group and two eyes in the control group. Persistent epithelial defect was reported in four eyes in the corticosteroid group and three eyes in the control group. Though the overall number of complications was more in the control group (10/19) compared to that in the corticosteroid group (n = 8/21) (risk ratio (RR) 1.38; 95% CI 0.69 to 2.76), the small number of participants in each group and the high proportion lost to follow‐up preclude reliable estimates of complication rates or differences in rates between treatment arms. </p> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> reported adverse events in two patients. One patient in the antibiotic‐steroid group experienced a possible recurrence of the ulcer at week 10 (five weeks after stopping all medications), but repeat culture was negative. One patient in the control group experienced a second corneal ulcer that was confirmed by culture. </p> <p><a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> found no systemic adverse events. There were four ocular adverse events and all occurred in the control group. </p> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> reported that there was no significant difference in the total number of adverse events (<a href="#CD005430-tbl-0002">Table 2</a>). The study also found no cases of other serious adverse event, such as endophthalmitis, intraocular pressure (IOP) &gt; 35 mm Hg, and myocardial infarction or stroke. The overall RR was 1.15 (95% CI 0.56 to 2.37) for the serious adverse events and 1.18 (95% CI 0.77 to 1.79) for the non‐serious adverse events. </p> </section> <section id="CD005430-sec-0079"> <h4 class="title">Quality of life measures</h4> <p>One study of 26 eyes of 26 participants collected data regarding quality of life using the VF‐14 (<a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a>). No difference in mean change in quality of life was reported (6.2 for the antibiotic‐only group and 9.7 for the antibiotic‐steroid group; standard deviations not available; P value = 0.42). </p> </section> <section id="CD005430-sec-0080"> <h4 class="title">Economic data</h4> <p>No included study reported economic data.</p> </section> <section id="CD005430-sec-0081"> <h4 class="title">Subgroup analyses</h4> <p>Outcomes in the only causative organism‐specific subgroup, <i>Nocardia</i> species, were reported in two articles based on the SCUT data (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). <i>Nocardia</i> species were the third most commonly isolated organism. Lalitha et al reported that there was no difference in visual acuity, time to re‐epithelialization, or perforation rates between the corticosteroid and placebo‐treated groups. However, in this organism‐specific subgroup, the use of corticosteroids was associated with significantly larger infiltrates or scar sizes at three months when compared to keratitis caused by other organisms, suggesting that the use of corticosteroids is not beneficial and may result in worse outcomes regarding corneal infiltrate and scarring when bacterial keratitis is caused by <i>Nocardia</i>. </p> <p>In the one‐year report of the SCUT trial, a regression analysis that used a model that included a <i>Nocardia‐</i> treatment arm interaction term found corticosteroid use associated with a mean one‐line improvement in BCVA at 12 months among patients with non‐<i>Nocardia</i> ulcers (MD ‐0.10 logMAR; 95% CI ‐0.19 to ‐0.02; P value = 0.02). No significant difference was observed in 12‐month BCVA for <i>Nocardia</i> ulcers (MD 0.18 logMAR; 95% CI ‐0.04 to 0.41; P value = 0.16). In the same article, the authors also reported that corticosteroids were associated with larger mean scar size at 12 months among <i>Nocardia</i> ulcers (MD 0.47 mm; 95% CI 0.06 to 0.88; P value = 0.02), while no difference was identified for the non‐<i>Nocardia</i> ulcers. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005430-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005430-sec-0082"></div> <section id="CD005430-sec-0083"> <h3 class="title" id="CD005430-sec-0083">Summary of main results</h3> <p>Microbial keratitis is a potentially sight‐threatening condition and an important cause of corneal inflammation. It has been estimated that 500,000 persons develop ulcerative keratitis annually around the world (<a href="./references#CD005430-bbs2-0018" title="WilhelmusKR . Indecision about corticosteroids for bacterial keratitis: an evidence‐based update. Ophthalmology2002;109(5):835‐42. ">Wilhelmus 2002</a>). </p> <p>We identified four randomized controlled trials for inclusion in this review. Based on review of the data from 612 eyes of 611 participants enrolled in those trials, the evidence regarding use of corticosteroids as adjuncts to antibiotics is inconclusive due to the small numbers of participants enrolled in three studies and the large number of enrollees with incomplete outcome data due to losses to follow‐up in all four studies. </p> <p>The investigators of the earliest trial reported no adverse effect when using dexamethasone 0.1% four times a day in addition to topical antimicrobial therapy (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-Carmichael-1990" target="_blank">Carmichael 1990</a>). The authors suggested that steroid treatment should be initiated 24 hours after antimicrobial therapy. Other helpful suggestions for clinicians have been proposed by <a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-Wilhelmus-2002" target="_blank">Wilhelmus 2002</a>. </p> <p>The Steroids for Corneal Ulcers Trial (SCUT) was a large randomized, placebo‐controlled, double‐masked, multicenter clinical trial that compared prednisolone sodium phosphate (1.0%) to placebo as adjunctive therapy for the treatment of bacterial corneal ulcers (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-SCUT-2012" target="_blank">SCUT 2012</a>). The pilot study for this trial included 42 participants with culture‐confirmed bacterial keratitis that were randomized to the same treatments used in SCUT (all participants received topical moxifloxacin 0.5%) (<a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-Srinivasan-2009" target="_blank">Srinivasan 2009</a>). Although corticosteroid treatment resulted in a statistically significant delay in re‐epithelialization, no difference in best corrected visual acuity (BCVA), infiltrate/scar size, or adverse events at three months was observed. </p> <p>Although SCUT randomized 500 participants, only 442 participants (88.4%) were evaluated three months later and 399 participants 12 months later (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). No clinically or statistically significant differences between treatment arms were observed for any outcome in this review. However, more participants in the placebo arm developed mildly increased intraocular pressure (IOP) (&gt; 25 but &lt; 35 mmHg) when compared to the corticosteroid‐treated group (P value = 0.04). Notably, subgroup analysis showed that corticosteroid treatment was associated with a benefit in visual acuity compared with the placebo group in participants with the worst visual acuity and central ulcer location at baseline. In the SCUT, 56 participants (11%) presented with ulcers caused by <i>Nocardia</i> species. When this subgroup of patients was analyzed separately (Lalitha et al), the use of corticosteroids was associated with a larger infiltrate or scar size at three months and 12 months when compared to placebo. </p> <p>In SCUT, most patients experienced the majority of BCVA improvement during the first three months after treatment was initiated, although smaller but still significant improvements were observed up to 12 months after starting treatment. </p> <p><a href="http://archie.cochrane.org/sections/documents/view?document=953305021509501283%26format=REVMAN#STD-Blair-2011" target="_blank">Blair 2011</a> found no significant difference between the corticosteroid and placebo groups with respect to residual ulcer size at 10 weeks compared with the baseline size, healing rate, or final BCVA. Only the clinician estimates of ulcer size at the slit lamp provided evidence of benefit of adjunctive corticosteroid. </p> <p>In summary, the available evidence does not support a benefit of corticosteroid use as adjunctive therapy for bacterial keratitis. Three studies were small in sample size and possibly underpowered to detect differences. The SCUT trial was designed to detect a difference between groups but the results may have limited generalizability (<a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a>). (See '<a href="#CD005430-sec-0087">Agreements and disagreements with other studies or reviews</a>' section). The available data regarding safety of topical corticosteroid is inconclusive. None of the three small studies found significant differences between groups, but the SCUT trial reported more risk of IOP elevation in the control group. Although three studies were relatively well‐designed and had large enough sample sizes to satisfy the power of detection, loss to follow‐up was an issue for all included studies. In addition, considering subgroup analyses and the generalizability of findings, one or more well‐designed and properly conducted randomized controlled trials are still desirable. </p> </section> <section id="CD005430-sec-0084"> <h3 class="title" id="CD005430-sec-0084">Overall completeness and applicability of evidence</h3> <p>As the mainstay of treatment for bacterial keratitis, topical antibiotics are used primarily to eliminate the causative organisms. However, host corneal inflammatory response may in some cases cause more damage than the infection itself. The use of topical corticosteroids in addition to antimicrobial therapy in the treatment of bacterial keratitis has been controversial for over 50 years. Their anti‐inflammatory activity may help control the host response, and reduce corneal neovascularization and scarring, thus favoring the clinical outcome. On the other hand, the immunosuppressive effect of corticosteroids may actually promote bacterial replication and slow recovery of the patient. Based on our review, the evidence regarding the effectiveness and safety of adjunctive corticosteroid use in bacterial keratitis is inconclusive. </p> </section> <section id="CD005430-sec-0085"> <h3 class="title" id="CD005430-sec-0085">Quality of the evidence</h3> <p>Based on our assessment of trial quality per pre‐specified criteria, we judged the overall quality of evidence as moderate. Random sequence generation was adequately performed in all four studies. Masking of participants, personnel, and outcome assessors was achieved in three studies, with the exception of <a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>. Compared with the protocol, the SCUT trial and its pilot study were consistent in reporting all pre‐specified outcomes. We did not find publicly available protocols for the other two studies. Incomplete outcome data was a major issue for all these four studies in that more than 10% of the participants were lost to follow‐up and not included in the final analyses, possibly biasing the findings from all four studies and, thus, of this review. The analysis of SCUT data regarding outcomes for <i>Nocardia</i> species organisms was an ancillary analysis and not based on randomization to treatment arm within that subgroup of patients. </p> </section> <section id="CD005430-sec-0086"> <h3 class="title" id="CD005430-sec-0086">Potential biases in the review process</h3> <p>We are unaware of any potential biases in the review process. We searched multiple databases to identify randomized controlled trials (RCTs) relevant to this review. As part of our search, we screened nearly 500 citations to identify the four RCTs included. Data extracted from reports focused on clinical and functional outcomes and were confirmed by at least two authors. Thus, our conclusion, i.e. that current evidence does not suggest a difference in the effectiveness of topical corticosteroid use adjunctive to antibacterial therapy in bacterial keratitis, is based on established, reproducible methods. </p> </section> <section id="CD005430-sec-0087"> <h3 class="title" id="CD005430-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>Steroids have been implicated as a risk factor for the development of corneal ulcers; however, the use of topical steroids adjunctive to antibiotics is still deliberated today. </p> <p>Several suggestions have been proposed by authors, such as to delay the use of steroids for at least 24 hours to exclude rapidly deteriorating infections and fungal ulcers (<a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a>). Other useful suggestions were published by <a href="./references#CD005430-bbs2-0018" title="WilhelmusKR . Indecision about corticosteroids for bacterial keratitis: an evidence‐based update. Ophthalmology2002;109(5):835‐42. ">Wilhelmus 2002</a>, which included certain recommendations such as to minimize corticosteroid use if inflammation is not near the visual axis and the corneal wound is healing adequately; to avoid the use of topical corticosteroid if the causative micro‐organisms are unknown and effective antibacterial therapy cannot be provided; and to continue a topical corticosteroid, usually at a lower frequency or concentration, for patients already justifiably using a topical corticosteroid for another serious ocular condition or inflammatory disease. Despite the fact that all of these recommendations seem prudent and may be useful clinically, they are not supported by any evidence in this review. </p> <p>In general, authors agree with this review, stating that there is no benefit or harm in using steroids adjunctive to antibiotics in the treatment of bacterial keratitis. One publication pointed out that the SCUT may not be applicable to the US population due to several key differences, such as the reduced number of contact lens wearers and the high incidence of trauma in the SCUT patient population, compared to a higher incidence of keratitis due to contact lenses and low incidence of trauma‐induced keratitis in western countries (<a href="./references#CD005430-bbs2-0053" title="TuliSS . Topical corticosteroids in the management of bacterial keratitis. Current Ophthalmology Reports2013;1(4):190‐3. ">Tuli 2013</a>). </p> <p>The American Academy of Ophthalmology (AAO) published a Preferred Practice Pattern (PPP) guideline on the management of bacterial keratitis on 21 September 2013 (<a href="./references#CD005430-bbs2-0022" title="Bacterial keratitis Preferred Practice Pattern (PPP) guideline. American Academy of Ophthalmology2013. ">AAO Bacterial Keratitis PPP 2013</a>). No conclusive evidence was provided as to the treatment effect of corticosteroids on clinical outcomes. However, the guideline recommended using only the minimum dose of corticosteroid required to alleviate inflammation and to avoid use of corticosteroids when the ulcer is associated with <i>Acanthamoeba, Nocardia</i>, fungus, or HSV (<a href="./references#CD005430-bbs2-0022" title="Bacterial keratitis Preferred Practice Pattern (PPP) guideline. American Academy of Ophthalmology2013. ">AAO Bacterial Keratitis PPP 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005430-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/urn:x-wiley:14651858:media:CD005430:CD005430-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_t/tCD005430-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Results from searching for studies for inclusion in the review" data-id="CD005430-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005430-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/urn:x-wiley:14651858:media:CD005430:CD005430-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_t/tCD005430-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005430-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005430-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/urn:x-wiley:14651858:media:CD005430:CD005430-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_t/tCD005430-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Steroid versus placebo for the treatment of corneal ulcers, Outcome 1 Time to re‐epithelialization." data-id="CD005430-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Steroid versus placebo for the treatment of corneal ulcers, Outcome 1 Time to re‐epithelialization. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/references#CD005430-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/media/CDSR/CD005430/image_n/nCD005430-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD005430-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Clinical outcomes reported in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><b>Visual acuity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect measure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean change in logMAR visual acuity from baseline, measured by ETDRS chart</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean BCVA from Snellen chart and then converted to a numerical equivalent number; linear regression model </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference in logMAR BCVA between groups from multiple linear regression model, using a protocol adapted from AREDS using a tumbling "E" chart </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean logMAR BCVA adapted from AREDS using a tumbling "E" chart; mean difference in logMAR BCVA between groups from multiple linear regression model </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time point(s) measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks, 3 months, 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks and 3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Steroid group: ‐0.31 (SD or 95% CI not reported)</p> <p>Control group: ‐0.18 (SD or 95% CI not reported)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1) Mean BCVA:</p> <p>Steroid group: mean pretreatment vision: 6; mean post‐treatment vision: 9.7</p> <p>Non‐steroid group: mean pretreatment vision: 6.4; mean post‐treatment vision: 9.2</p> <p>2) Linear regression model: linear regression showed no difference between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks: steroid group had 0.024 better logMAR BCVA (95% CI ‐0.092 to 0.044)</p> <p>3 months: steroid group had 0.009 better logMAR BCVA (95% CI ‐0.085 to 0.068)</p> <p>12 months: steroid group had 0.04 better logMAR BCVA (95% CI ‐0.12 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1) Mean (SD) logMAR BCVA:</p> <p>3 weeks: steroid group: 0.66 (0.68); placebo group: 0.75 (0.75)</p> <p>3 months: steroid group: 0.71 (0.72); placebo group: 0.59 (0.75)</p> <p>2) Multiple linear regression model:</p> <p>3 weeks: steroid group had 0.19 lower (better) logMAR BCVA (95% CI ‐0.52 to 0.15)</p> <p>3 months: steroid group had 0.09 lower (better) logMAR BCVA (95% CI ‐0.41 to 0.24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interpretation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><b>Healing rate/ulcer size</b> </p> <p><b>/time to re‐epithelialization</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Effect measure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean change in ulcer area from baseline (mm<sup>2</sup>), measured by photographic measurement and by clinician estimate (slit lamp) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean size of ulcer (mm<sup>2</sup>) healed per day, measured at the slit lamp </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference in diameter of ulcer area from linear regression models, measured by a Haag‐Streit 900 slit lamp biomicroscope; median time to re‐epithelialization (days) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference in diameter of ulcer area from linear regression models, measured by a Haag‐Streit 900 slit lamp biomicroscope </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time point(s) measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks, 3 months, 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 weeks and 3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Photographic measurement:</p> <p>Steroid group: ‐4.388 mm<sup>2</sup> </p> <p>Control group: ‐1.919 mm<sup>2</sup> </p> <p>(SD or 95% CI not reported)</p> <p>Clinician estimate (slit lamp):</p> <p>Steroid group: ‐4.206 mm<sup>2</sup> </p> <p>Control group: ‐0.789 mm<sup>2</sup> </p> <p>(SD or 95% CI not reported)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Steroid group: 0.36 mm<sup>2</sup> per day </p> <p>Control group: 0.30 mm<sup>2</sup> per day </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer size:</p> <p>3 weeks: steroid group had 0.05 mm smaller diameter of scar area (95% CI ‐0.09 to 0.15) </p> <p>3 months: steroid group had 0.06 mm smaller diameter of scar area (95% CI ‐0.07 to 0.17) </p> <p>12 months: steroid group had 0.03 mm smaller diameter of scar area (95% CI ‐0.12 to 0.18) </p> <p>Time to re‐epithelialization:</p> <p>Steroid group: 7.5 days (95% CI 5.5 to 8.5 days)</p> <p>Placebo group: 7 days (95% CI 5.5 to 8.5 days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer size:</p> <p>3 weeks: steroid group had 0.57 mm smaller diameter of scar area (95% CI 1.5 to 0.37)</p> <p>3 months: steroid group had 0.33 mm smaller diameter of scar area (95% CI 1.4 to 0.75)</p> <p>Time to re‐epithelialization:</p> <p>steroid group: 8.6 days (SD 4.7)</p> <p>placebo group: 6.3 days (SD 3.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interpretation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups from photographic measurement;</p> <p>statistically significant difference between groups from clinician estimate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No statistically significant difference between groups was found</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>AREDS: Age Related Eye Disease Study<br/> BCVA: best corrected visual acuity<br/> CI: confidence interval<br/> ETDRS: Early Treatment Diabetic Retinopathy Study<br/> SD: standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Clinical outcomes reported in the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005430-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse events reported in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse event</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0001" title="BlairJ , HodgeW , Al‐GhamdiS , BalabanianR , LowcockB , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: double‐blinded randomized clinical trial. Canada Journal of Ophthalmology2011;46(1):40‐5. HodgeWG , BlairJ , Al‐GhambdiS , BalabanianR , LowcockBC , PanYI , et al. Comparison of antibiotic‐only and antibiotic‐steroid combination treatment in corneal ulcer patients: a double‐blinded, randomized clinical trial ‐ interim report. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4275. ">Blair 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0002" title="CarmichaelTR , GelfandY , WelshNH . Topical steroids in the treatment of central and paracentral corneal ulcers. British Journal of Ophthalmology1990;74(9):528‐31. ">Carmichael 1990</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0003" title="AcharyaN , SrinivasanM , MahalakshmiR , JayashreeD , PrajnaL , HouseJ , et al. Steroids for Corneal Ulcers Treatment ‐ SCUT pilot study results. Investigative Ophthalmology and Visual Science2006;47:ARVO E‐abstract 4752. ChenA , PrajnaL , SrinivasanM , AcharyaN , LietmanT . Does in vitro susceptibility testing predict clinical outcomes in bacterial keratitis? Results from the Steroids for Corneal Ulcers Trial (SCUT) pilot study. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 4277. DulkuS . Subgroup analysis in the steroids for corneal ulcers trial. Archives of Ophthalmology2012; Vol. 130, issue 6:807‐8. GargP , VaziraniJ . Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea?. Expert Review of Ophthalmology2013;8(1):41‐4. LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , RavindranM , et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical Infectious Diseases2012;54(10):1381‐7. LalithaP , SrinivasanM , RajaramanR , RavindranM , MascarenhasJ , PriyaJL , et al. Nocardia keratitis: clinical course and effect of corticosteroids. American Journal of Ophthalmology2012;154(6):934‐9. McClinticSM , PrajnaNV , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , et al. Visual outcomes in treated bacterial keratitis: four years of prospective follow‐up. Investigative Ophthalmology and Visual Science2014;55(5):2935‐40. OldenburgCE , LalithaP , SrinivasanM , ManikandanP , BharathiMJ , RajaramanR , et al. Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis. Investigative Ophthalmology and Visual Science2013;54(2):1522‐6. RayKJ , PrajnaL , SrinivasanM , GeethaM , KarpagamR , GliddenD , et al. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. JAMA Ophthalmology2013;131(3):310‐3. RayKJ , SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , GliddenDV , et al. Early addition of topical corticosteroids in the treatment of bacterial keratitis. JAMA Ophthalmology2014;132(6):737‐41. SeeCW , SrinivasanM , SaravananS , OldenburgCE , EsterbergEJ , RayKJ , et al. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiology2012;19(6):407‐13. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. Corticosteroids for bacterial keratitis ‐ The Steroids for Corneal Ulcers Trial (SCUT). Archives of Ophthalmology2012;130(2):143‐150. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , GliddenDV , et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Archives of Ophthalmology2012;130(2):151‐7. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , O'BrienKS , et al. The Steroids for Corneal Ulcers Trial (SCUT): secondary 12‐month clinical outcomes of a randomized controlled trial. American Journal of Ophthalmology2014;157(2):327‐33. SrinivasanM , MascarenhasJ , RajaramanR , RavindranM , LalithaP , RayKJ , et al. Visual recovery in treated bacterial keratitis. Ophthalmology2014;121(6):1310‐1. SyA , SrinivasanM , MascarenhasJ , LalithaP , RajaramanR , RavindranM , et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative Ophthalmology and Visual Science2012;53(1):267‐72. ">SCUT 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><a href="./references#CD005430-bbs2-0004" title="SrinivasanM , LalithaP , MahalakshmiR , PrajnaNV , MascarenhasJ , ChidambaramJD , et al. Corticosteroids for bacterial corneal ulcers. British Journal of Ophthalmology2009;93(2):198‐202. ">Srinivasan 2009</a> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Steroid</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR (95% CI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of the ulcer</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.60 (0.12 to 58.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45 (0.04 to 4.60)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Second ulcer</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/12</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29 (0.01 to 6.50)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Corneal thinning</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.06 to 13.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.14)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Corneal perforation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.06 to 13.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.88 (0.32 to 2.38)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 3.94)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Uncontrolled infection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18 (0.01 to 3.56)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent epithelial defect</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.21 (0.31 to 4.71)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.63 (1.04 to 2.54)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Epithelial breakdown</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/21</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/19</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.06 to 13.48)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.40 (0.45 to 4.35)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic infection</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.00 (0.12 to 73.29)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in hypopyon</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (0.25 to 3.95)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IOP elevation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.04 to 0.90)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37 (0.02 to 8.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Worsening infiltrate</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.25 (0.70 to 7.21)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0/20</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37 (0.02 to 8.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13/250</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.30 to 1.59)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>/</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="13"> <div class="table-footnote"> <p>CI: confidence interval<br/> IOP: intraocular pressure<br/> RR: risk ratio </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse events reported in the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/full#CD005430-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005430-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Steroid versus placebo for the treatment of corneal ulcers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Time to re‐epithelialization <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Steroid versus placebo for the treatment of corneal ulcers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005430.pub3/references#CD005430-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005430.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005430-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005430-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005430-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD005430-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005430\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005430\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005430\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005430\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005430\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9nGOjNGw&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005430.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005430.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005430.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005430.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005430.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724816382"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005430.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724816387"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005430.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e6c0ea813f4ca',t:'MTc0MDcyNDgxOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 